CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Clinical trial NCT05436093 · RECRUITING
Trial details
- NCT number
- NCT05436093
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2026-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.